Good toward the purchase of prescriptions for BELVIQ® (lorcaserin HCI) CIV or BELVIQ XR® (lorcaserin HCI) CIV for up to 13 uses per year. Limited to 1 prescription per patient for any 30-day period. For patients with commercial insurance that covers the product, the patient pays the first $30 for BELVIQ XR or $40 for BELVIQ, and then Eisai Inc. will provide no more than $160 off the patient’s out-of-pocket costs per commercially insured, covered prescription. For patients paying cash who have commercial insurance that does not cover the product, Medicare Part D, TRICARE, or are uninsured, Eisai will provide no more than $195 off the patient’s cash price per 30 day fill. Save this card to reuse each month up to the expiration date or program discontinuation. No substitutions permitted.
If you have any questions about the program rules or require additional information, please call 1-855-BELVIQ1 (1-855-235-8471).
Financial assistance is available. For more about our Patient Assistance Program for those in financial need, click here.
BELVIQ/BELVIQ XR is a FDA-approved prescription weight-loss medication that, when used with diet and exercise, can help some adults (body mass index [BMI] ≥27 kg/m2) living with extra weight, with a weight-related medical problem, or adults living with obesity (BMI ≥30 kg/m2), lose weight and keep it off. It is not known if BELVIQ/BELVIQ XR when taken with other prescription, over-the-counter, or herbal weight-loss products is safe and effective. It is not known if BELVIQ/BELVIQ XR changes your risk of heart problems, stroke, or death due to heart problems or stroke.
BELVIQ®/BELVIQ XR® is a federally controlled substance (CIV) because it may be abused or lead to drug dependence.
For more information about BELVIQ®/BELVIQ XR® talk to your Healthcare Provider and see the full Product Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or